(19)
(11) EP 1 546 398 A2

(12)

(88) Date of publication A3:
14.04.2005

(43) Date of publication:
29.06.2005 Bulletin 2005/26

(21) Application number: 03791659.0

(22) Date of filing: 26.08.2003
(51) International Patent Classification (IPC)7C12Q 1/68
(86) International application number:
PCT/US2003/024799
(87) International publication number:
WO 2004/020580 (11.03.2004 Gazette 2004/11)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 28.08.2002 US 406432 P
28.08.2002 US 230007

(71) Applicant: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventors:
  • KAYTES, Paul, S.
    Kalamazoo, MI 49048 (US)
  • TENG, Chi-Hse
    Portage, MI 49024 (US)

(74) Representative: Hayles, James Richard et al
Pfizer Limited,Patents Department,Ramsgate Road
SandwichKent CT13 9NJ
SandwichKent CT13 9NJ (GB)

   


(54) SINGLE NUCLEOTIDE POLYMORPHISMS DIAGNOSTIC FOR SCHIZOPHRENIA